References
World Health Organization (2002) Anti-tuberculosis drug resistance in the world: the WHO/IUATLD Global Project on Anti-Tuberculosis Drug Resistance Surveillance. WHO/TB, Geneva
Espinal AM, Laszlo A, Simonsen L, Boulahbl F, Kim SJ, Reneiro A, Hoffner S, Rieder HL, Binkin N, Dye C, Williams R, Raviglione MC (2001) Global trends in resistance to antituberculosis drugs. N Engl J Med 344:1294–1303
Canetti G, Fox W, Khomenko A, Mahler HT, Menon NK, Mitchison PA, Rist NA, Smalev NA (1969) Advances in techniques of testing mycobacterial drug sensitivity, and the use of sensitivity tests in tuberculosis control programmes. Bull World Health Organ 41:21–43
WHO Geneva/IUATLD Paris (1998) Guidelines for surveillance of drug resistance in tuberculosis. Int J Tuberc Lung Dis 2:72–89
Tahaoglu K, Kizkin O, Karagoz T, Tor M, Partal M, Sadoglu T (1994) High initial and acquired drug resistance in pulmonary tuberculosis in Turkey. Tuber Lung Dis 75:324–328
Sevim T, Atac G, Hatipoglu T (1999) Primary and secondary drug resistance rates of 2161 patients with pulmonary tuberculosis, hospitalized in our center between 1993–1995 (in Turkish). Solunum Hasta 10:231–237
Ogul EC, Gur A, Ozdemir A (1999) Primary and secondary drug resistance rates of pulmonary tuberculosis patients, hospitalized in Yedikule Chest Diseases Training Hospital between 1995–1997 (in Turkish). Solunum Hasta 10:238–244
Kýlýcarsalan Z, Albal H, Kiyan E, Aydemir N (2002) Drug resistance in pulmonary tuberculosis in Istanbul. Eur J Clin Microbiol Infect Dis 21:763–764
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Pazarli, P., Karagoz, T., Yazicioglu Mocin, O. et al. Drug resistance in pulmonary tuberculosis in Turkey. Eur J Clin Microbiol Infect Dis 26, 431–433 (2007). https://doi.org/10.1007/s10096-007-0302-8
Published:
Issue Date:
DOI: https://doi.org/10.1007/s10096-007-0302-8